Federal Parity Tied to Lower Out of Pocket Mental Health Spending
FRIDAY, Aug. 3, 2018 -- Federal parity under the Mental Health Parity and Addiction Equity Act (MHPAEA) is associated with lower average annual out-of-pocket (OOP) mental health spending among children with mental health conditions, according to a study published in the August issue of Pediatrics.
Alene Kennedy-Hendricks, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues used a difference-in-differences approach to compare commercially insured children aged 3 to 18 years in 2008 who were continuously enrolled in plans newly subject to parity under MHPAEA with those enrolled in plans never subject to parity. Mental health service use and spending outcomes were assessed.
The researchers found that parity was associated with $140 lower average annual OOP mental health spending among children with mental health conditions who were enrolled in plans subject to parity, an amount that was lower than expected given changes in the comparison group. Parity was associated with $234 lower average annual OOP mental health spending among children who were in the ≥85th percentile in total mental health spending.
"MHPAEA was associated with increased financial protection on average for children with mental health conditions and among those at the higher end of the spending distribution," the authors write. "Estimated reductions in OOP spending were likely too modest to have substantially reduced financial burden on families of children with particularly high mental health expenditures."
One author disclosed financial ties to the pharmaceutical industry.
© 2020 HealthDay. All rights reserved.
Posted: August 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.